Related Experiment Videos
The genetics of mental illness: implications for practice.
1National Institute of Mental Health, Bethesda, MD 20892-9669, USA.
Bulletin of the World Health Organization
|July 8, 2000
Summary
Simple models of mental disorders are outdated. Complex genetic and environmental interactions, not single genes or neurotransmitters, contribute to mental illness risk and development.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Background:
- Traditional models of mental disorders, their causes, and neural substrates are increasingly insufficient.
- Simple explanations involving single genes or neurotransmitter levels for conditions like depression and schizophrenia are being replaced.
- The idea of a single causative gene for mental disorders has been superseded by the concept of genetic complexity.
Purpose of the Study:
- To highlight the limitations of current simple models for understanding mental disorders.
- To emphasize the shift towards understanding mental disorders as complex interactions between multiple genes and environmental factors.
- To discuss the implications of these evolving models for neuroscience, genetics, and clinical practice.
Main Methods:
- Review of current understanding in genetics and neuroscience regarding mental disorders.
- Analysis of the limitations of previous etiological models.
- Synthesis of emerging concepts of genetic complexity and gene-environment interactions.
Main Results:
- Mental disorders result from complex interactions between multiple genes and non-genetic factors, influencing an individual's risk.
- Advances in genetics and neuroscience are leading to more sophisticated models of brain and behavior complexity.
- Understanding gene expression timing and function during development is crucial for identifying environmental risk factors.
Conclusions:
- Complex genetics of mental disorders necessitates renewed research in epidemiology and classification, explaining family transmission patterns.
- Future therapies will target pathogenic processes, enabled by understanding gene function within molecular, cellular, and systems neuroscience.
- Personalized treatments targeting specific pathophysiological pathways are anticipated, moving beyond symptom-based interventions.